Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

NCT03570476 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Terminated due to slow accrual

Conditions

Prostate Adenocarcinoma Without Neuroendocrine Differentiation
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage IIA Prostate Cancer AJCC v8
Stage IIB Prostate Cancer AJCC v8
Stage IIC Prostate Cancer AJCC v8

Interventions

DRUG: Olaparib
PROCEDURE: Radical Prostatectomy

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]